33
Participants
Start Date
January 31, 2008
Primary Completion Date
May 31, 2011
Study Completion Date
May 31, 2011
Methylphenidate Hydrochloride
Run in period of 5mg QD,PO for 2 weeks followed by 5mg BID,PO for 8 weeks (full daily dose of 10mg). Followed by a 2 week taper period of 5mg QD,PO to complete 12 week cycle.
Matched Placebo
Run in period of 5mg QD,PO for 2 weeks followed by 5mg BID,PO for 8 weeks (full daily dose of 10mg). Followed by a 2 week taper period of 5mg QD,PO to complete 12 week cycle.
UHN Princess Margaret Hospital, Toronto
Collaborators (1)
Sanofi
INDUSTRY
University Health Network, Toronto
OTHER